Sign inJoin waitlistJoin the waitlist

Francisco Vazquez

Professor, Section Chief, Lymphoma Section · University of Texas M D Anderson Cancer Center

Credentials: · · · · · ·

History

Section Chief · University of Texas M D Anderson Cancer Center
Present
University of Texas M D Anderson Cancer Center
Present
University of Texas M D Anderson Cancer Center
Present

University of Texas M D Anderson Cancer Center
2005–2006
Pathology
Baylor College of Medicine
2003–2005
Baylor College of Medicine
2002–2003
Hematopathology Research Training
University of Texas M D Anderson Cancer Center
1999–2002
Universidad de Navarra
1994–1997
Doctor of Medicine
1988–1992

Research

Activating FLT3 mutations are detectable in chronic and blast phase of chronic myeloproliferative disorders other than chronic myeloid leukemia
American Journal of Clinical Pathology · 2006 · 53 citations
Safety and efficacy of ibrutinib in combination with rituximab and lenalidomide in previously untreated follicular and marginal zone lymphoma: An open label, phase 2 study
Cancer · 2024 · 11 citations
Multifocal dactylitis as the sole clinical expression of sarcoidosis
Case report · The Journal of Rheumatology · 2000 · Last of 6 authors · 7 citations

Jeffrey Medeiros
2 papers
Carlos Bueso-Ramos
1 paper
Christopher Flowers
1 paper
FS
Felipe Samaniego
1 paper
Fredrick Hagemeister
1 paper
Hun Lee
1 paper
Jason Westin
1 paper
Loretta Nastoupil
1 paper
Luis Fayad
1 paper
MG
Max Gordon
1 paper · 1 as a fellow
NF
Nathan Fowler
1 paper
Paolo Strati
1 paper

Grants

Lymphoma Outcomes SPORE
National Cancer Institute · U54
Project lead · $459.8K · University of Tx Md Anderson Can Ctr
2025–2030
Smoothened as a Novel Signal Stabilization Scaffold in Doxorubicin Resistance
National Cancer Institute · R01
PI · $2.4M · University of Miami School of Medicine
2019–2025
Role of Sonic Hedgehog Signaling Pathway in Diffuse Large B-Cell Lymphoma
National Cancer Institute · K08
Contact PI · $511.9K · University of Miami School of Medicine
2010–2014